Every major AI advance was built on massive amounts of data. ChatGPT was built on top of the Internet, new coding agents train on millions of public codebases, and AlphaFold leveraged the Protein DataBank. Learn about the ways that synthetic biologists are leveraging the combination of DNA sequencing and synthesis to fuel new modeling advances.

A new era in synthetic biology is unfolding as AI, genome sequencing, and DNA synthesis technologies come together to unlock breakthroughs once considered unattainable. In gene therapy, AI is poised to address one of the most pressing and costly hurdles of the field: efficient and targeted gene delivery. This talk will examine how advanced, AI-enabled approaches to synthetic biology for gene delivery are transcending the limitations of naturally occurring vectors, broadening tissue targeting to organs such as the eye, muscle, and brain, and accelerating the path from concept to clinical success. Attendees will gain actionable insights into harnessing these AI-driven tools to improve patient access, reduce costs, and usher in a new generation of transformative genomic medicines.